September 2022 EGRP Cancer Epidemiology News

EGRP Cancer Epidemiology News


Upcoming Grant Changes from 2023 NIH Policy for Data Management and Sharing

In October 2020, NIH issued a Final NIH Policy for Data Management and Sharing (NOT-OD-21-013), which will require NIH-funded researchers to submit with their grant application: 1) a full plan outlining how scientific data from their research will be managed and shared; 2) a budget for data management and sharing with a brief description (half page) outlining budget items for data sharing and management.

On January 25, 2023, the new policy will come into effect for any NIH-funded research, regardless of the research grant budget size, that will generate scientific data. This new policy replaces the 2003 NIH Data Sharing Policy. The 2015 Genomic Data Sharing Policy will remain in effect. NIH recently released additional information on the implementation changes for genomic data sharing plans (see NOT-OD-22-198).

To help the research community prepare for implementation of the new policy, NIH also provides the following supplemental information and resources:

Stay Informed!

The first of two public NIH webinars about the new policy was held on August 11, 2022. The August 11 webinar was recordedExternal Web Site Policy and is publicly available. The second webinar will take place on September 22, 2022, from 1:30 – 3:00 PM EDT. All investigators are encouraged to listen to these webinars. Register for the September webinar.

NCI’s Epidemiology and Genomics Research Program (EGRP) will also continue updating the information on its Resource/Data Sharing web pages as more information becomes available.

Funding Opportunities

  • RFA-HG-22-008, Multi-Omics for Health and Disease – Disease Study Sites (U01, Clinical Trial Optional)
  • RFA-HG-22-009, Multi-Omics for Health and Disease – ‘Omics Production Centers (U01, Clinical Trial Not Allowed)
  • RFA-HG-22-010, Multi-Omics for Health and Disease – Data Analysis and Coordination Center (U01, Clinical Trial Not Allowed)
  • RFA-CA-22-031, Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01, Clinical Trial Optional)
  • RFA-CA-22-032, Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24, Clinical Trial Not Allowed)
  • RFA-OD-22-016, Environmental Influences on Child Health Outcomes (ECHO) Laboratory Core (U24, Clinical Trial Not Allowed)*
  • RFA-OD-22-017, Open Competition: ECHO Pregnancy Cohort Study Sites (UG3/UH3, Clinical Trial Not Allowed)
  • RFA-OD-22-018, Limited Competition: ECHO Pregnancy and Pediatric Cohort Study Sites (UG3/UH3, Clinical Trial Not Allowed)
  • RFA-OD-22-019, Limited Competition: ECHO Cohort Study Sites for Pediatric Follow Up (UG3/UH3, Clinical Trial Not Allowed)
  • RFA-OD-22-020, ECHO Measurement Core (U24, Clinical Trial Not Allowed)*
  • RFA-OD-22-021, ECHO Coordinating Center (U2C, Clinical Trial Not Allowed)*
  • RFA-OD-22-022, ECHO Data Analysis Center (U24, Clinical Trial Not Allowed)*
  • RFA-CA-22-054, The Early Detection Research Network: Clinical Validation Centers (U01, Clinical Trial Optional)
  • RFA-CA-22-045, NCI Outstanding Investigator Award (R35, Clinical Trial Optional)
  • RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (R01, Clinical Trial Optional)
  • RFA-CA-22-041, The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00, Clinical Trial Not Allowed)
  • PAR-22-233, Time-Sensitive Opportunities for Health Research (R61/R33, Clinical Trial Not Allowed)
  • PAR-23-024, Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1, Clinical Trial Optional)
  • PAR-22-242, Bioengineering Research Grants (R01, Clinical Trial Not Allowed)
  • PAR-22-243, Bioengineering Research Grants (R01, Clinical Trial Optional)
  • NOT-OD-22-135, Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity
  • NOT-OD-22-208, NOSI: Research on the Health of Women of Understudied, Underrepresented and Underreported Populations (Admin Supp Clinical Trial Optional)
  • NOT-RM-23-001, Notice of Information: Upcoming Research Opportunity Announcement for Community Partnerships to Advance Science for Society Program: Community-Led, Health Equity Structural Intervention Initiative (OT2, Clinical Trial Optional)
  • NOT-HD-22-036, Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels (U24, Clinical Trial Not Allowed)
  • NOT-RM-23-002, Notice of Intent to Publish a Funding Opportunity Announcement for Community Partnerships to Advance Science for Society: Coordination Center (U24, Clinical Trial Optional)

* NCI is not participating in the funding opportunity announcement.

Grants Policy Announcements

  • NOT-OD-22-198, Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023
  • NOT-OD-22-205, Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies with Human Participants

Requests for Information (RFI)

  • NOT-OD-22-186, NIH RFI on NIH-Wide Strategic Plan for Research on the Health of Women (responses requested by September 29, 2022)
  • NOT-RM-22-016, Soliciting Ideas for New NIH Common Fund Programs (responses requested by September 30, 2022)

Career & Training Opportunities

Research Resources

NCI/NIH News and Blog Posts

Stay Connected

Subscribe for Updates

Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.

Subscribe to the E-Newsletter

Need Help?

EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.

Email Us
(240) 276-6730